Summarized patient outcomes/complications of amplatzer septal occluder were reported in a research article in a subject population with atrial septal defect.Some of the complications reported were headache, vomiting, hospitalization and unexpected medical intervention.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.Literature attachment: headaches in children after transcatheter device closure of atrial septal defects: a single centre experience.
|
The article, "headaches in children after transcatheter device closure of atrial septal defects: a single centre experience", was reviewed.The article presented a case study of a 15-year-old, 114.2 kg, female patient with an atrial septal defect (asd) with a maximum diameter of 29mm.It was reported that on an unknown date, a 30mm amplatzer septal occluder was implanted.One week post-procedure, the patient presented to the emergency room with severe unilateral headaches and vomiting.A decision was made to change the patient's post-procedure medication therapy from aspirin to clopidogrel.The article concluded that the study suggested a minimal estimate of 15% as the incidence of headache in children who undergo tdc.This estimate can inform counseling prior to tdc.Determination of the true incidence will require focused prospective data collection.[the primary and corresponding author was joshua griesman, the hospital for sick children, toronto, ontario, canada, with corresponding email: joshua.Griesman@sickkids.Ca].
|